Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04202627 · ClinicalTrials.gov registry record

Biomarker Development in LGMD2i

A clinical trial of Muscular Dystrophies and Limb Girdle Muscular Dystrophy, sponsored by ML Bio Solutions.

Completed
Registry status
101
Enrollment target
11
Study locations

NCT04202627 is a study of Muscular Dystrophies and Limb Girdle Muscular Dystrophy that has completed, run by ML Bio Solutions. The registered enrollment target is 101 participants, below the 890-participant average among 11 other Muscular Dystrophies trials with a reported enrollment target (89% lower). The trial reports 11 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04202627, a study of Muscular Dystrophies and Limb Girdle Muscular Dystrophy, has completed, sponsored by ML Bio Solutions.

COMPLETED
Registry status
101 participants
Enrollment target
11
Study locations

Study Summary

The overall goal of this natural history study is to define the key LGMD2i phenotypes as measured by standard clinical outcome assessments (COAs), and to validate a muscle biomarker for LGMD2i to support therapeutic development.

Conditions Studied

Muscular Dystrophies Limb Girdle Muscular Dystrophy

Study Locations (11)

California

  • University of California Irvine - Irvine

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Florida

  • University of Florida - Gainesville

Iowa

  • University of Iowa - Iowa City

Kansas

  • University of Kansas Medical Center - Kansas City

Maryland

  • Kennedy Krieger Institute - Baltimore

Missouri

  • Washington University School of Medicine - St Louis

North Carolina

  • Atrium Health - Charlotte

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2019-12-01
Est. Completion 2022-10-10

Sponsor

ML Bio Solutions

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04202627

The ClinicalTrials.gov registry entry for NCT04202627 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 890-participant average among 11 other Muscular Dystrophies trials with a reported enrollment target (89% lower). The listed sponsor is ML Bio Solutions, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Muscular Dystrophies appearing as the primary indexed condition, and to 0 interventions.

NCT04202627 reports 11 study locations spanning 11 distinct geographic areas - top geographies include California, Colorado, Florida.

Frequently Asked Questions

What is clinical trial NCT04202627 about?

NCT04202627 is a clinical study titled "Biomarker Development in LGMD2i". The overall goal of this natural history study is to define the key LGMD2i phenotypes as measured by standard clinical outcome assessments (COAs), and to validate a muscle biomarker for LGMD2i to support therapeutic development.

What is the current status of trial NCT04202627?

This trial is currently completed. The enrollment target is 101 participants. The study started on 2019-12-01. Estimated completion is 2022-10-10.

What conditions does trial NCT04202627 study?

This clinical trial studies the following conditions: Muscular Dystrophies, Limb Girdle Muscular Dystrophy.

Who is sponsoring clinical trial NCT04202627?

This trial is sponsored by ML Bio Solutions, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04202627 being conducted?

This trial has 11 study locations across California, Colorado, Florida, Iowa, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Muscular Dystrophies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Muscular Dystrophies

All registered trials for this condition

Limb Girdle Muscular Dystrophy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.